M&A Deal Summary |
|
---|---|
Date | 2014-03-11 |
Target | DPx Holdings BV |
Sector | Life Science |
Buyer(s) |
JLL Partners
DSM-Firmenich |
Deal Type | Buyout (LBO, MBO, MBI) |
Deal Value | 2.7B USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1988 |
PE ASSETS | 5.8B USD |
Size | Mega |
Type | Sector Agnostic |
JLL Partners, Inc. is a private equity investment firm that invests alongside management in middle-market companies. JLL prefers control investments in sectors such as healthcare services, medical products, food and consumer products, chemicals, broadcasting, transportation, automotive, industrial manufacturing, and distribution. In addition to traditional buyout transaction, JLL also seeks distressed/turnaround situations. JLL Partners was formed in 1988 and is based in New York City.
DEAL STATS | # |
---|---|
Overall | 23 of 40 |
Sector (Life Science) | 5 of 7 |
Type (Buyout (LBO, MBO, MBI)) | 6 of 9 |
State (Massachusetts) | 2 of 3 |
Country (United States) | 22 of 38 |
Year (2014) | 1 of 1 |
Size (of disclosed) | 1 of 9 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-11-19 |
Patheon BV
Durham, North Carolina, United States Patheon BV is a global provider of pharmaceutical development and manufacturing services. With approximately 9,000 professionals worldwide, Patheon provides a comprehensive, integrated and highly customizable set of solutions to help clients of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle. A Healthier World. Delivered. |
Buy | $2.6B |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-03-12 |
CCBR-SYNARC
Newark, California, United States CCBR-SYNARC, Inc. is a medical image-analysis, subject-recruitment, and biochemical marker services enable life-science industry clients to execute clinical trials accurately while decreasing the time, uncertainty, and cost of product development. |
Sell | - |
Category | Company |
---|---|
Founded | 1902 |
Sector | Chemicals |
Employees | 27,926 |
Revenue | 10.6B EUR (2023) |
DSM-Firmenich specializes in development, manufacture and marketing of performance materials, nutritional and pharmaceutical ingredients and industrial chemicals. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics. DSM-Firmenich founded in 1902 and is based in Kaiseraugst, Switzerland.
DEAL STATS | # |
---|---|
Overall | 22 of 28 |
Sector (Life Science) | 6 of 9 |
Type (Buyout (LBO, MBO, MBI)) | 1 of 1 |
State (Massachusetts) | 2 of 2 |
Country (United States) | 11 of 11 |
Year (2014) | 2 of 2 |
Size (of disclosed) | 1 of 13 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-01-21 |
Roche Vitamins and Fine Chemicals
Kaiseraugst, Switzerland Roche Vitamins and Fine Chemicals is a producer of vitamins, carotenoids, nutritional lipids, enzymes and other healthy ingredients for human and animal nutrition. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-03-02 |
Euroresins Benelux bv
Budel,, Netherlands Euroresins is a distributor of products to the composite resins industry with activities in nine countries in Europe. |
Sell | - |